Scinovex
articleTop 1% cited

Randomized placebo-controlled trial of prednisone for paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome

AIDS · 2010 · Vol. 24(15) · pp. 2381–2390
Graeme MeintjesRobert J. WilkinsonChelsea MorroniDominique J. PepperKevin RebeMolebogeng X. RangakaTolu OniGary Maartens

Abstract

Prednisone reduced the need for hospitalization and therapeutic procedures and hastened improvements in symptoms, performance, and quality of life. It is important to investigate for drug-resistant tuberculosis and other causes for deterioration before administering glucocorticoids.

Infectious Diseases and TuberculosisPneumocystis jirovecii pneumonia detection and treatmentTuberculosis Research and EpidemiologyMedicinePrednisoneInterquartile rangePlaceboClinical endpointAdverse effectInternal medicineImmune reconstitution inflammatory syndromeRandomized controlled trialSurgery

MeSH terms

AdultDouble-Blind MethodGlucocorticoidsHumansMaleMiddle AgedPlacebosPrednisoneTuberculosisHIV InfectionsTreatment OutcomeCD4 Lymphocyte CountAntiretroviral Therapy, Highly ActiveImmune Reconstitution Inflammatory SyndromeYoung Adult

Funding

  • Wellcome Trust
Citations
404
FWCI
33.81
field-weighted impact
References
36
Percentile
100%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

Randomized placebo-controlled trial of prednisone for paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome · Scinovex